MIRZYME THERAPEUTICS LIMITED

B7 4BB (West Midlands)

Start Date

End Date Funded Value Relevance

CSV

25 50 100

£444,361

Nov 23 - Oct 24

Preclinical development of the first orally-active substance for the treatment of preeclampsia

Innovate UK award to MIRZYME THERAPEUTICS LIMITED and Homira May Rezai

{{facetGroup.name}}

{{getFilterText(facet,showCount)}}